Literature DB >> 6336717

Preeclampsia -- a state of prostaglandin deficiency? Urinary prostaglandin excretion, the renin-aldosterone system, and circulating catecholamines in preeclampsia.

E B Pedersen, N J Christensen, P Christensen, P Johannesen, H J Kornerup, S Kristensen, J G Lauritsen, P P Leyssac, A Rasmussen, M Wohlert.   

Abstract

Urinary excretion of prostaglandin E2 (PGE2) and F2 alpha (PGF2 alpha), plasma concentrations of renin, aldosterone, norepinephrine (NE) and epinephrine (E) were determined during pregnancy, 5 days, 3, and 6 months after delivery in preeclampsia, normotensive pregnant, and nonpregnant control subjects. The PGE2 was higher in normotensive pregnant control subjects than in nonpregnant subjects. In preeclampsia, PGE2 was reduced to nonpregnant level. PGF2 alpha was the same in preeclampsia and in normotensive pregnancy, but elevated when compared to the normotensive nonpregnant control group. Plasma concentrations of renin and aldosterone were increased during pregnancy, but considerably less in preeclampsia than during normotensive pregnancy. NE and E were the same as in nonpregnant subjects during both hypertensive and normotensive pregnancy. All parameters were normal 3 months after delivery. There were no correlations between PGE2, PGF2 alpha, plasma concentrations of renin, aldosterone, NE, or E and blood pressure level in third trimester either in preeclampsia or in normotensive pregnancy. PGE2 was positively correlated to plasma concentrations of renin. It is suggested that the lack of renal PGE2 in preeclampsia might be responsible for the decrease in renal blood flow and sodium excretion. It is hypothesized that preeclampsia is a state of prostaglandin deficiency. The changes in the renin-aldosterone system may be secondary to changes in prostaglandin concentration both in preeclampsia and normotensive pregnancy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6336717     DOI: 10.1161/01.hyp.5.1.105

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Urine exosomes from healthy and hypertensive pregnancies display elevated level of α-subunit and cleaved α- and γ-subunits of the epithelial sodium channel-ENaC.

Authors:  Maria R Nielsen; Britta Frederiksen-Møller; Rikke Zachar; Jan S Jørgensen; Mie R Hansen; Rikke Ydegaard; Per Svenningsen; Kristian Buhl; Boye L Jensen
Journal:  Pflugers Arch       Date:  2017-04-12       Impact factor: 3.657

2.  Mechanisms of enhanced vascular reactivity in preeclampsia.

Authors:  Nikita Mishra; William H Nugent; Sunila Mahavadi; Scott W Walsh
Journal:  Hypertension       Date:  2011-09-26       Impact factor: 10.190

3.  Renin-Angiotensin-Aldosterone Profiles in Pregnant Women With Chronic Hypertension.

Authors:  Line Malha; Cristina P Sison; Geraldine Helseth; Jean E Sealey; Phyllis August
Journal:  Hypertension       Date:  2018-06-25       Impact factor: 10.190

Review 4.  Urinary serine proteases and activation of ENaC in kidney--implications for physiological renal salt handling and hypertensive disorders with albuminuria.

Authors:  Per Svenningsen; Henrik Andersen; Lise H Nielsen; Boye L Jensen
Journal:  Pflugers Arch       Date:  2014-12-09       Impact factor: 3.657

Review 5.  Hypertension in pregnancy. Pathophysiology and management.

Authors:  W F Lubbe
Journal:  Drugs       Date:  1984-08       Impact factor: 9.546

Review 6.  The role of serotonin in the preeclampsia-eclampsia syndrome.

Authors:  C P Weiner
Journal:  Cardiovasc Drugs Ther       Date:  1990-01       Impact factor: 3.727

Review 7.  Secondary hypertension. An overview of its causes and management.

Authors:  D H Streeten; G H Anderson
Journal:  Drugs       Date:  1992-06       Impact factor: 9.546

8.  Evidence against the hypothesis that prostaglandins are the vasodepressor agents of pregnancy. Serial studies in chronically instrumented, conscious rats.

Authors:  K P Conrad; M C Colpoys
Journal:  J Clin Invest       Date:  1986-01       Impact factor: 14.808

9.  Is urinary excretion of plasminogen associated with development of pre-eclampsia? An observational, explorative case-control study.

Authors:  Lise H Nielsen; Camilla Kronborg; Erik Vittinghus; Gitte Kitlen; Boye L Jensen; Ulla B Knudsen; Per G Ovesen
Journal:  BMJ Open       Date:  2019-06-21       Impact factor: 2.692

Review 10.  Aspirin for the prevention and treatment of pre-eclampsia: A matter of COX-1 and/or COX-2 inhibition?

Authors:  Katrina M Mirabito Colafella; Rugina I Neuman; Willy Visser; A H Jan Danser; Jorie Versmissen
Journal:  Basic Clin Pharmacol Toxicol       Date:  2019-09-11       Impact factor: 4.080

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.